evaluate the pharmaceuticals company saxenda on glp-1 efficacy / effectiveness Multi-Sector Impacts of GLP-1RA Drugs GLP-1 analogs, new trend in

Van Bloemendaal L, IJzerman RG, Ten Kulve JS, et al

81 OhtsukaK.NimuraY.YasuiK

RAW 264.7 cells were plated and treated in starving medium (DMEM containing 1% P/S)

Scheme 33

They tried a few tricks: DPP-4-resistant versions: tweaking the GLP-1 molecule so DPP-4 cant see where to cut it Fatty acid tails: causing the GLP-1 to latch onto albumin in your blood, hiding from DPP-4 Encapsulation: wrapping the molecule in protective coatings so it survives longer before being exposed to enzymes These hacks meant the drug could hang out in the bloodstream for hours, or even days, instead of minutes

Novo Nordisk and Eli Lilly have denied allegations that their GLP-1 medications were defectively labeled or caused the injuries alleged in these lawsuits